Lupus & antiphospholipid syndrome
Clarifying misbeliefs about hydroxychloroquine (HCQ): developing the HCQ benefits versus harm decision aid (HCQ-SAFE) per low health literacy standards
Authors' conclusion
HCQ-SAFE is a stakeholder-informed feasible shared decision-making tool that enhances communication and can potentially improve knowledge, clarify misbeliefs and engage patients in treatment decisions, including those with limited English proficiency.
Study context
- Population
- Patients with SLE at visits across four clinics, including non-English-speaking patients
- Participants
- 40 patient visits
- Outcome
- Usability and feasibility on Likert scales (0-7) and net promoter score (0%-100%)
Methodological detailscollaborative stakeholder-informed development, Agency for Healthcare Research and Quality (AHRQ) low literacy principles, four clinics
- Collaborative stakeholder-informed development
- AHRQ low literacy principles
- Four clinics
Main finding
As reported in the abstract
- Reviewed in all eligible patient visits, average duration (min)
- ≈8
- Non-English-speaking patients
- 25%
- Patients scoring 100% on knowledge post-test
- All
- Decisional conflicts after using HCQ-SAFE
- 0
- Likelihood to recommend to peers (clinicians and patients)
- 100%
Original publication
Clarifying misbeliefs about hydroxychloroquine (HCQ): developing the HCQ benefits versus harm decision aid (HCQ-SAFE) per low health literacy standards. Lupus Sci Med. Published 27 July 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →